BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10758057)

  • 1. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.
    Querejeta R; Varo N; López B; Larman M; Artiñano E; Etayo JC; Martínez Ubago JL; Gutierrez-Stampa M; Emparanza JI; Gil MJ; Monreal I; Mindán JP; Díez J
    Circulation; 2000 Apr; 101(14):1729-35. PubMed ID: 10758057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.
    López B; Querejeta R; Varo N; González A; Larman M; Martínez Ubago JL; Díez J
    Circulation; 2001 Jul; 104(3):286-91. PubMed ID: 11457746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives.
    Maceira AM; Barba J; Varo N; Beloqui O; Díez J
    Hypertension; 2002 Apr; 39(4):923-8. PubMed ID: 11967251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
    Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
    Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.
    Díez J; Querejeta R; López B; González A; Larman M; Martínez Ubago JL
    Circulation; 2002 May; 105(21):2512-7. PubMed ID: 12034658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
    Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
    Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis.
    Díez J; Panizo A; Gil MJ; Monreal I; Hernández M; Pardo Mindán J
    Circulation; 1996 Mar; 93(5):1026-32. PubMed ID: 8598066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
    Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
    Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
    J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta in hypertensives with cardiorenal damage.
    Laviades C; Varo N; Díez J
    Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?
    López B; González A; Lasarte JJ; Sarobe P; Borrás F; Díaz A; Barba J; Tomás L; Lozano E; Serrano M; Varo N; Beloqui O; Fortuño MA; Díez J
    J Hypertens; 2005 Mar; 23(3):625-32. PubMed ID: 15716706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
    Ravassa S; López B; Querejeta R; Echegaray K; San José G; Moreno MU; Beaumont FJ; González A; Díez J
    J Hypertens; 2017 Apr; 35(4):853-861. PubMed ID: 28253222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
    dos Santos Moreira C; Serejo F; Alcântara P; Ramalhinho V; Braz Nogueira J
    Rev Port Cardiol; 2015 May; 34(5):309-14. PubMed ID: 25958256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Rábago G; Díez J
    Hypertension; 2014 Mar; 63(3):483-9. PubMed ID: 24366078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmented QRS complexes are a marker of myocardial fibrosis in hypertensive heart disease.
    Bekar L; Katar M; Yetim M; Çelik O; Kilci H; Önalan O
    Turk Kardiyol Dern Ars; 2016 Oct; 44(7):554-560. PubMed ID: 27774963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients.
    Lin YH; Shiau YC; Yen RF; Lin LC; Wu CC; Ho YL; Huang PJ
    Ultrasound Med Biol; 2004 Jul; 30(7):885-91. PubMed ID: 15313321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.
    Lindsay MM; Maxwell P; Dunn FG
    Hypertension; 2002 Aug; 40(2):136-41. PubMed ID: 12154103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.